Literature DB >> 17206471

The transduction of His-TAT-p53 fusion protein into the human osteogenic sarcoma cell line (Saos-2) and its influence on cell cycle arrest and apoptosis.

Lei Jiang1, Yushu Ma, Jinzhi Wang, Xinyi Tao, Dongzhi Wei.   

Abstract

The p53 gene is a tumor suppressor gene. It encodes a nuclear phosphoprotein p53 involved in the regulation of cell cycle arrest and apoptosis to maintain the genomic integrity of the cell. As mutations of p53 gene are found in most human cancers, p53 protein becomes a hot target in the research of anticancer therapy. In the present study, an 11-amino acid domain of TAT protein which has been demonstrated to be able to transduce across cell membranes was fused with p53. The result revealed that the fusion protein His-TAT-p53 accumulated in the nucleus and inhibited the growth of the Saos-2 cells. Besides apoptosis, an increased percentage of G2 phase suggested that the transduction of His-TAT-p53 into cells might be associated with a G2 arrest of cell cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206471     DOI: 10.1007/s11033-006-9044-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

1.  p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; T Vallenius; G Rijksen; T P Mäkela; R H Medema
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

2.  Refolding and structural characterization of the human p53 tumor suppressor protein.

Authors:  Stefan Bell; Silke Hansen; Johannes Buchner
Journal:  Biophys Chem       Date:  2002-05-02       Impact factor: 2.352

Review 3.  Delivery of proteins and peptides into live cells by means of protein transduction domains: potential application to organ and cell transplantation.

Authors:  Ricardo L Pastori; Dagmar Klein; Melina M Ribeiro; Camillo Ricordi
Journal:  Transplantation       Date:  2004-06-15       Impact factor: 4.939

4.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.

Authors:  H Nagahara; A M Vocero-Akbani; E L Snyder; A Ho; D G Latham; N A Lissy; M Becker-Hapak; S A Ezhevsky; S F Dowdy
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

5.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.

Authors:  M Green; P M Loewenstein
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

6.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

7.  In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug.

Authors:  M V Blagosklonny; W S el-Deiry
Journal:  Int J Cancer       Date:  1996-07-29       Impact factor: 7.396

8.  Intracellular delivery of p53 fused to the basic domain of HIV-1 Tat.

Authors:  Jiyoon Ryu; Hak Joo Lee; Kyeong-Ae Kim; Jae Yong Lee; Kil Soo Lee; Jinseu Park; Soo Young Choi
Journal:  Mol Cells       Date:  2004-04-30       Impact factor: 5.034

9.  No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides.

Authors:  S D Krämer; H Wunderli-Allenspach
Journal:  Biochim Biophys Acta       Date:  2003-01-31

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  4 in total

1.  Chimeric p53 as an alternative therapy for hypoxic tumors.

Authors:  Jun-Ho Lee; Hua Lu
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

2.  Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts.

Authors:  Corey Heffernan; Huseyin Sumer; Luis F Malaver-Ortega; Paul J Verma
Journal:  Stem Cells Int       Date:  2012-04-26       Impact factor: 5.443

3.  Secretory TAT-peptide-mediated protein transduction of LIF receptor α-chain distal cytoplasmic motifs into human myeloid HL-60 cells.

Authors:  Q Sun; J Xiong; J Lu; S Xu; Y Li; X P Zhong; G K Gao; H Q Liu
Journal:  Braz J Med Biol Res       Date:  2012-06-21       Impact factor: 2.590

4.  AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells.

Authors:  Luigi Sapio; Ersilia Nigro; Angela Ragone; Alessia Salzillo; Michela Illiano; Annamaria Spina; Rita Polito; Aurora Daniele; Silvio Naviglio
Journal:  J Oncol       Date:  2020-01-22       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.